 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that MRVI's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Maravai LifeSciences Holdings (MRVI, $5.17) RSI Indicator left the oversold zone on November 22, 2023

Maravai LifeSciences Holdings (MRVI, $5.02) RSI Indicator left the oversold zone on November 17, 2023

Maravai LifeSciences Holdings (MRVI, $5.19) RSI Indicator left the oversold zone on November 14, 2023

Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI  Get Free Report) have received an average recommendation of Moderate Buy from the eight brokerages that are presently...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Consensus Rating of "Moderate Buy" from Analysts

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled...

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

In trading on Wednesday, drugs shares were relative laggards, down on the day by about 2.8%. Helping drag down the group were shares of Durect, down about 76.2% and shares of Maravai LifeSciences...

Video: Wednesday Sector Laggards: Drugs, Television & Radio Stocks

TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence...

TriLink BioTechnologies Expands Capabilities with Launch of Analytical Sciences Center of Excellence

Maravai LifeSciences Holdings (MRVI, $7) RSI Indicator left the oversold zone on October 30, 2023

SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023

Maravai LifeSciences Holdings (MRVI, $8.61) RSI Indicator left the oversold zone on October 10, 2023

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Watchers	881
52-Wk Low	$4.52
52-Wk High	$16.90

Market Cap	$684.74M
Volume (M)	1.99M
52-Wk High	$16.90
52-Wk Low	$4.52

MRVI Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals